In a significant advancement for clinical research within Thailand, Clinixir, a pioneer in clinical research innovation, is proud to announce a strategic Memorandum of Understanding (MOU) with Burapha University. This partnership underscores both parties’ commitment to enhancing medical research and innovation. The formal signing event was held at the Faculty of Medicine, Burapha University, attended by executives and scholars from both institutions.
Dr. Kanokwan Pornprasit, CEO of Clinixir, and Asst. Prof. Dr. Taweelarp Tansawat, Dean of the Faculty of Medicine at Burapha University, presided over the ceremony. They delivered compelling presentations that outlined the goals and expected outcomes of this collaboration, highlighting the shared vision to set new benchmarks in clinical research.
Also attending were Assoc. Prof. Dr. Kitti Krungkaipetch, Vice Dean for Research, Services, Academic, and International Affairs at the Faculty of Medicine, Burapha University and Asst. Prof. Dr. Krittin Kittikornchaichan, Assistant Vice Dean for Research and Academic Services at the Faculty of Medicine, Burapha University.
This partnership is poised to significantly enhance the capabilities of the BUU-CRC, with a focus on conducting high-impact clinical research that could shape health policies and improve patient care practices both in Thailand and globally. The collaboration aims to leverage Clinixir’s expertise in innovative research methodologies alongside Burapha University’s robust academic foundation and state-of-the-art facilities.
For additional information, interviews, or inquiries, please contact us at enquiries@clinixir.com for more information and visit www.clinixir.com to learn more about our services.
